- Home
- ITRM vs OPAD Comparison
ITRM vs OPAD Comparison
Compare ITRM & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- OPAD
- Stock Information
- Founded
- ITRM 2015
- OPAD 2015
- Country
- ITRM Ireland
- OPAD United States
- Employees
- ITRM N/A
- OPAD N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- OPAD Real Estate
- Sector
- ITRM Health Care
- OPAD Finance
- Exchange
- ITRM Nasdaq
- OPAD Nasdaq
- Market Cap
- ITRM 40.0M
- OPAD 43.7M
- IPO Year
- ITRM 2018
- OPAD N/A
- Fundamental
- Price
- ITRM $0.68
- OPAD $4.32
- Analyst Decision
- ITRM Strong Buy
- OPAD Hold
- Analyst Count
- ITRM 2
- OPAD 5
- Target Price
- ITRM $7.00
- OPAD $2.41
- AVG Volume (30 Days)
- ITRM 749.8K
- OPAD 23.9M
- Earning Date
- ITRM 11-13-2025
- OPAD 11-03-2025
- Dividend Yield
- ITRM N/A
- OPAD N/A
- EPS Growth
- ITRM N/A
- OPAD N/A
- EPS
- ITRM N/A
- OPAD N/A
- Revenue
- ITRM N/A
- OPAD $703,352,000.00
- Revenue This Year
- ITRM N/A
- OPAD N/A
- Revenue Next Year
- ITRM $249.35
- OPAD $23.26
- P/E Ratio
- ITRM N/A
- OPAD N/A
- Revenue Growth
- ITRM N/A
- OPAD N/A
- 52 Week Low
- ITRM $0.61
- OPAD $0.91
- 52 Week High
- ITRM $3.02
- OPAD $6.35
- Technical
- Relative Strength Index (RSI)
- ITRM 43.17
- OPAD 57.11
- Support Level
- ITRM $0.61
- OPAD $3.75
- Resistance Level
- ITRM $0.76
- OPAD $5.44
- Average True Range (ATR)
- ITRM 0.05
- OPAD 1.31
- MACD
- ITRM 0.01
- OPAD -0.03
- Stochastic Oscillator
- ITRM 49.65
- OPAD 53.23
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.